Safe and effective opioid use in pain management: A clinician’s prescribing perspective: pharmacists: on demand
Pharmacists in community-based practice.
Universal program number: 0401-0000-17-057-H01-P
CE Broker tracking number: 20-573861
Activity type: Knowledge-based
It goes without saying that we are still in the middle of a crisis with continued increases in both addiction and overdose deaths from both prescription and street-obtained opioids. Both federal and state governments have enacted (or suggested) a variety of actions in an attempt to stem the tide. This session will review a number of consensus-based measures that healthcare providers/prescribers use to assess patients for treatment with opioids, including risk/benefit analysis, establishing tangible treatment goals, patient-provider agreements, informed consent, monitoring patients for efficacy, side effects and safety, including aberrant behaviors associated with abuse risk. Within this framework, there will be emphasis on select points where communication between prescribing clinicians and pharmacists is paramount to ensure the best and safest outcomes for patients and the community.
- Discuss how a prescribing clinician accurately assesses patients with pain for consideration of an opioid trial.
- Describe how realistic goals for pain management and restoration of function are conveyed to patients.
- Review the step-wise approach for initiating opioids in patients with acute pain.
- Discuss logistics surrounding faxed, e-scribed, future-dated and blank signed prescriptions.
- Counsel patients and caregivers about use, misuse, abuse, diversion and overdose.
- List options by which pharmacists and prescribers can work together to ensure patient safety.
To obtain credit:
To complete the program and receive CPE credit, view all lesson content and complete the learning assessment by submitting answers online. A minimum test score of 70% is needed to obtain credit. After successfully completing the learning assessment, participants must complete a program evaluation and claim the available CPE credit. Participants also must verify personal information required by CPE monitor and/or CE Broker (for Florida license holders) prior to submitting CPE credit claims. Official statements of credit are available only through CPE Monitor located at NABP.net.
If you have a question, visit our Frequently Asked Questions page.
All other customer service questions should be directed to DRSNCE@lf1925.com.
Drug Store News is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This CPE activity is approved for pharmacists and is worth 1.0 contact hours (0.1 CEUs). The activity is available for CE credit through June 28, 2020.
Jody Agins, MSN, RNP, FNP/GNP-BC, clinical services director, Agape Hospice and Palliative Care, Tucson, Arizona; founder and executive director of Collaborative Medical Provider Group (PLLC), Tucson, Arizona; primary care provider, Caremore Touch (Anthem)
Jody Agins and the DSN editorial and continuing education staff do not have any actual or potential conflicts of interest in relation to this lesson.
- 1.00 Pharmacist